Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors

A series of novel pyridone derivatives were identified as non-nucleoside HBV inhibitors via bioisosterism and hybrid pharmacophore-strategy.159